688046 药康生物
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资79,007-11.04%88,81280,04369,19868,536
投资性房地产0--0000
固定资产568,061-0.90%573,247493,222486,699194,079
在建工程24,76710.27%22,46190,85289,603171,670
无形资产72,0520.95%71,37249,04647,34148,514
商誉0--0000
其他非流动资产412,79715.40%357,702149,709227,226303,907
1,156,6853.87%1,113,593862,871920,067786,706

流动资产
货币资金415,147-14.69%486,621701,372560,166421,708
应收账款425,59910.56%384,962350,806269,390185,216
存货86,84019.02%72,96154,19747,09249,471
其他流动资产783,766-2.87%806,930603,399780,875810,616
1,711,353-2.29%1,751,4741,709,7741,657,5231,467,010

流动负债
短期借款158,187-15.55%187,32588,04076,15712,206
应付票据0--0000
应付帐款71,0824.33%68,13472,175101,86050,787
其他流动负债248,355-8.59%271,685210,980188,392151,077
477,623-9.39%527,144371,196366,409214,070
流动资产净值1,233,7300.77%1,224,3301,338,5781,291,1141,252,940
资产总额减流动负债2,390,4152.25%2,337,9232,201,4502,211,1812,039,647

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债111,5300.73%110,72666,72386,52461,933
111,5300.73%110,72666,72386,52461,933

总权益
    实收股本410,0000.00%410,000410,000410,000410,000
    储备项目1,868,8852.84%1,817,1971,724,7261,714,6561,567,714
股东权益2,278,8852.32%2,227,1972,134,7262,124,6561,977,714
非控股权益0--0000